We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Fusion Antibodies Plc | LSE:FAB | London | Ordinary Share | GB00BDQZGK16 | ORD 4P |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
3.70 | 3.80 | 3.85 | 3.75 | 3.85 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 2.9M | -2.6M | -0.0437 | -0.86 | 2.23M |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
16:29:48 | O | 34 | 3.80 | GBX |
Date | Time | Source | Headline |
---|---|---|---|
28/3/2024 | 17:00 | UK RNS | Fusion Antibodies PLC Total Voting Rights |
11/3/2024 | 15:04 | UK RNS | Fusion Antibodies PLC Holding(s) in Company |
11/3/2024 | 09:10 | UK RNS | Fusion Antibodies PLC Holding(s) in Company |
08/3/2024 | 15:09 | UK RNS | Fusion Antibodies PLC Holding(s) in Company |
05/3/2024 | 10:40 | UK RNS | Fusion Antibodies PLC Result of General Meeting and Total Voting Rights |
29/2/2024 | 17:00 | UK RNS | Fusion Antibodies PLC Total Voting Rights |
27/2/2024 | 14:18 | ALNC | TRADING UPDATES: Sondrel wins USD23 million contract |
27/2/2024 | 07:00 | UK RNS | Fusion Antibodies PLC First purchase order under MSA |
14/2/2024 | 11:27 | ALNC | IN BRIEF: Fusion Antibodies raises GBP1.4 million via placing |
14/2/2024 | 07:15 | UK RNS | Fusion Antibodies PLC Grant of options and issue of shares to directors |
Fusion Antibodies (FAB) Share Charts1 Year Fusion Antibodies Chart |
|
1 Month Fusion Antibodies Chart |
Intraday Fusion Antibodies Chart |
Date | Time | Title | Posts |
---|---|---|---|
22/3/2024 | 18:56 | ☆ Fusion Antibodies: from discovery to Clinical supply ☆ | 3,849 |
28/11/2023 | 16:25 | NEW FAB Fusion Antibodies The Next AVCT | 64 |
18/9/2020 | 14:23 | Fusion Antibody II | 51 |
17/9/2020 | 08:25 | COVID. RAPID PROGRESS MADE. Ј3M RAISED | 58 |
08/2/2012 | 21:34 | Fabio Capello Resigns....... | 9 |
Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
---|---|---|---|---|
2024-03-28 16:29:49 | 3.80 | 34 | 1.29 | O |
2024-03-28 16:28:10 | 3.80 | 26 | 0.99 | O |
2024-03-28 16:13:45 | 3.70 | 7,500 | 277.65 | O |
2024-03-28 16:12:43 | 3.70 | 5,600 | 207.31 | O |
2024-03-28 15:40:23 | 3.90 | 76 | 2.96 | O |
Top Posts |
---|
Posted at 28/3/2024 08:20 by Fusion Antibodies Daily Update Fusion Antibodies Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker FAB. The last closing price for Fusion Antibodies was 3.85p.Fusion Antibodies currently has 59,453,714 shares in issue. The market capitalisation of Fusion Antibodies is £2,229,514. Fusion Antibodies has a price to earnings ratio (PE ratio) of -0.86. This morning FAB shares opened at 3.85p |
Posted at 27/2/2024 10:31 by troutisout "Fusion Antibodies (FAB), specialists in pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications, announced it has received a first purchase order under the master services agreement (MSA) with a leading diagnostics company details of which were announced on 14 February 2024. FAB said reaching this agreement with a world class diagnostics provider positively reinforces the value to the wider commercial world of Fusion Antibodies’ technologies and capabilities. In this case it is the generation of antibodies in diagnostics products.Comment: It could be argued that fundamentally FAB is now on track as a recovery situation, with the purchase order and recent funding. Only a rise in the share price is missing." |
Posted at 14/2/2024 13:07 by dreamtwister careful jock the share price will dip below the price of the placings. |
Posted at 23/1/2024 16:30 by jaknife I have no particular interest in FAB anymore, it's too small a company. But I would be interested to see any calculations that anyone has done of (a) what FAB's current monthly cash burn is, and (b) therefore what FAB's current cash position is.Do people routinely do these sorts of calculations before investing? JakNife |
Posted at 18/1/2024 08:36 by cyberbub Having done my research, the company seems to have a lot going for it, the market cap is ludicrously low for what it has, especially with the NCI collaboration which should generate good news flow throughout 2024. As always with AIM, shorters and spivs have hammered the cap down whenever the company needed cash, to the current crazy valuation. It would definitely be at the very least 10x the current cap if listed in the US today. But we are where we are. There are still justifiable concerns over their cash level, but the company is taking firm action to reduce outflows, and it seems that revs are starting to pick up. If it seems clear in the next couple of months that they can get away without another spivs' front-run placing, then the share price should rocket IMHO. Maybe even a director loan or a small £250-500k private placing, are options to see them through? Good luck all. |
Posted at 08/12/2023 10:37 by jaknife luckyabbeygale,Look back at the chart for FAB. Can you see that massive fall in the share price in May? From c. 40p to about 6p? That coincided with this RNS when the 5p placing was announced: It's unlikely that the next placing will have such a huge discount. But it's also unlikely that FAB will make it through 2024 without yet another placing. If you disagree then buy, it's your choice and the decision is solely down to you. JakNife |
Posted at 07/12/2023 18:26 by daniel It's better to stay with the FAB's board that said the fund is enough to carry them through to BE. They certainly know more than you guys, and should have learnt their lessons. When the news of another deal hits the market, it could quadruple the share price in a day.You never anticipated the NCI deal, likewise you don't know what's coming next. |
Posted at 06/12/2023 16:20 by clocktower JakNife does not need to try to depress the share price the facts alone do that.If you ignore the facts and want to ramp this dog like WTP did to try to support his own loss making position, you are likely to end up all the poorer, like he found out when he pumped the FAB share.🤣 Good luck though. |
Posted at 06/12/2023 16:08 by daniel Hey... that's deflection. You are a spiv on Aim. You are here trying to depress the share price while your handlers are begging FAB to take funds. Stop the nonsense. There will be no more fundraising, Full Stop! |
Posted at 06/12/2023 14:31 by daniel Don't listen to Jaknife. He works for certain brokerage firms seeking to undermine companies by depressing the share prices; in the hope of getting cheap shares after front-selling. Check out his history with many companies. He is a scammer that manipulates unseasoned PI's.You can see him targeting fundraising but totally ignoring the OptiMal Collaboration agreement. That's the usual pattern. But you wander where the donkey had been when the share price was much higher. I am looking to invest in this company, but his presence is depressant to the share price. |
Posted at 20/5/2023 09:40 by hedgehog 100 JakNife 6 Apr '23 - 18:29 - 3279 of 3333 0.010000 4 1"Here's another hugely dilutive placing that's been agreed in the sector: It's a chunky raise but at 1p it's an 84% discount to the closing price before it was previously suspended. All arrows point to a fund raise for FAB that materially dilutes current shareholders. JakNife" Well done to JakNife ... his AGY example was even the precise % discount as FAB's. dave454519 May '23 - 10:15 - 3283 of 3333 0 1 1 "Bloody hell that is savage. At least they did not have the nerve to say they were "pleased" to announce" Not in yesterday's first RNS Dave, but they still managed to get in two 'pleased to say/announce' yesterday:- 19/05/2023 10:00 UK Regulatory (RNS & others) Fusion Antibodies PLC Placing, Subscription and Retail Offer LSE:FAB Fusion Antibodies Plc " ... Fusion Antibodies CEO, Adrian Kinkaid said : "We are pleased to say that we have been able to raise funds in an extremely challenging market, ..." ..." 19/05/2023 10:01 UK Regulatory (RNS & others) Fusion Antibodies PLC REX Retail Offer LSE:FAB Fusion Antibodies Plc "Fusion Antibodies plc (AIM: FAB) is pleased to announce a retail offer via REX (the "REX Retail Offer") of ordinary shares ("Ordinary Shares") of 4 pence each in the capital of the Company (the "REX Retail Offer Shares") ... The issue price of the Placing Shares and Subscription Shares is 5 pence (the "Issue Price"). The price of the REX Retail Offer Shares is equal to the Issue Price. ..." volsung 19 May '23 - 10:20 - 3288 of 3333 0 0 1 "Not the best Belfast share" No, but the tiny number of London-listed N.I. shares includes former 15-bagger Kainos (KNOS) (still currently an 8.8-bagger from its 2015 IPO price of 139p); and FD Technologies (FDP) - currently a 37.6-bagger from its 2002 IPO price of 50p. See the "Rockpool Acquisitions (ROC)" thread for details (it's a Northern Ireland shell company currently arranging a RTO):- |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions